CV Joachim Jose
Joachim Jose studied biology at Saarland University, Saarbrücken, and obtained his doctoral degree in 1994 with a thesis on the structure and reaction mechanism of bacterial ureases.
During his time as a Post-Doc in the group of Prof. Thomas F. Meyer at the Max-Planck-Institute for Biology in Tübingen, he was mainly involved in the discovery of a new family of secreted proteins: the autotransporters. The family of ‘autotransporter’ proteins was first described in his publication together with F. Jähnig and T.F. Meyer in Molecular Microbiology (1995, 18: 380-82).
From 1998 until 2003, he was Assistant Professor (C1) in the group of Prof. Rolf W. Hartmann, Pharmaceutical and Medicinal Chemistry at Saarland University and obtained his habilitation with a thesis on the evolutive design of drugs and biocatalysts by bacterial surface display.
In 2004, Joachim Jose accepted an offer of the Heinrich-Heine-University Düsseldorf for a Professorship (C3) in Bioanalytics at the Institute for Pharmaceutical and Medicinal Chemistry, where he was appointed Head of the Institute in 2008. Since March 2011, he is a Full professor (W3) and Chair for Pharmaceutical and Medicinal Chemistry at the University Münster. His awards include the GDCh/DPhG Innovation Award in Medicinal Chemistry in 1998, the SaarLB Science Award in 2004 and the "Phoenix Pharmazie Wissenschaftspreis" (award for best publication in the field of Pharmaceutical chemistry) in 2023. Moreover, he was awarded a corresponding member of the French National Academy of Pharmacy in 2009. From 2020 to 2022, he was Dean of FB 12 - Faculty of Chemistry and Pharmacy at University of Münster.
Joachim Jose is co-founder of two start-up companies in the field of 'drug screening and selection' (Pharmacelsus, founded in 2000) and 'biocatalytic synthesis and evolutive drug design' (Autodisplay Biotech, 2008).
His research is mainly focused on the application of “autodisplay”, a technology platform that has been developed in his group and which is based on the autotransporter secretion mechanism. Current applications include the expression of human target enzymes for inhibitor testing, evolutive drug design by library expression and HT screening, biocatalytic synthesis of drugs and building blocks, as well as biosensor development by membrane technologies. Joachim Jose is married and has one son.
Personal data sheet (ORCID ID-Nr.: 0000-0002-0666-2676)
|
1989 |
Diploma in Biology (main subjects: microbiology, genetics, biochemistry) at the University of Saarbrücken and research assistant in the Department of Microbiology. |
| 1994 | Thesis, “Structure and reaction mechanism of urease from St. xylosus”, Promotion to a Dr. rer. nat. |
| 1994-97 | Post-Doc in the group of Prof. Thomas F. Meyer at the Max-Planck-Institute for Biology, Tübingen, Department of Infection Biology, and at the MPI for Infection Biology, Berlin, Department Molecular Genetics. |
| 1997 | Senior Researcher in the group of Prof. Rolf W. Hartmann in the Department of Pharmaceutical and Medicinal Chemistry, Saarland University, Saarbrücken. |
| 1998 | Assistant Professor (C1) at Saarland University, Saarbrücken. Innovation award in Medicinal Chemistry, jointly awarded by the German Chemical Society (GDCH) and the German Pharmaceutical Society (DPhG). |
| 2000 | Co-founder of the Start-up company Pharmacelcus GmbH, CRO Drug Absorption Screening. http://www.pharmacelsus.com Founding member of the center for Bioinformatics (ZBI), member of the ZBI council (2000–2005). http://www.zbi.uni-saarland.de/ |
| 2004 | SaarLB Science award. Associate Professor (C3) in Bioanalytics at the Institute of Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-University, Düsseldorf. |
| 2008 | Head of the Institute of Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-University, Düsseldorf. Co-founder of the Start-up Company Autodisplay Biotech GmbH, for biocatalytic synthesis and evolutive drug design. http://www.autodisplay-biotech.com. Awarded corresponding member of the French National Academy for Pharmacy. |
| since 2011 | Full Professor (W3) and Chair for Pharmaceutical and Medicinal Chemistry at the University of Münster. |
| 2013 |
Medal of the Faculty for Biology and Pharmacy of the University Claude Bernard, Lyon, France |
|
2012-2014 and 2016-2020 |
Executive Director of the Institute for Pharmaceutical and Medicinal Chemistry at the University of Münster. |
| 2014 - 2016 | Deputy senator of the University of Münster |
| 2015 | Chairman of TTMC 2015 (1st European Conference on Therapeutic Targets and Medicinal Chemistry) |
| 2017 | Associate editor of the open access journal Pharmaceuticals |
| 2017-2020 |
Board member of GP2A, European Association for Medicinal Chemistry |
| 2020-2022 | Dean of FB 12 Chemistry and Pharmacy |
| 2023 | Phoenix Pharmazie Wissenschaftspreis (award for best publication in the field of Pharmaceutical chemistry), for co-authoring the study Bathia et al. (2022) ACS Cent Sci, 8:636–655. |
| 2024 | Chairman of the 9th International Conference on Protein Kinase CK2 |
Memberships in scientific organisations:
Gesellschaft für Biochemie und Molekularbiologie (GBM, previously GBCH)
Vereinigung für Allgemeine und Angewandte Mikrobiologie (VAAM)
Deutsche Pharmazeutische Gesellschaft (DPhG)
Gesellschaft für Chemische Technik und Biotechnologie (DECHEMA)
American Society for Microbiology (ASM)
Gesellschaft Deutscher Chemiker (GDCH)
GP2A (Group for the Promotion of Pharmaceutical chemistry in Academia)
Research network: